Corporate Venture Capitalist
Knows what makes a company acquirable, and what makes acquirers wait.
In eyecare, capital and regulatory approvals are no longer what decides the outcome. Execution between the investment and the exit is. We fund, embed, and operate alongside a capable company, and carry it to an acquisition at its true worth.
Now reviewing a small number of companies for the current cohort.
They fail in the stretch between the check and the exit — where a company has to build a commercial engine, hit the milestones that de-risk it, and reach a buyer before the money runs out. Capital is abundant. Approval is achievable. Execution is the scarce, decisive asset.
Private capital directed at the specific inflection points that matter — faster and simpler than a strategic's multi-month cycle.
Hands-on commercial, regulatory, hiring and partnership work with clear ownership. We operate — we do not merely advise.
Revenue, repeatability and validation — the buyer-readable proof the market can actually price.
Positioning and process discipline for the strategic acquirers, sold at a premium rather than a fire-sale.
Knows what makes a company acquirable, and what makes acquirers wait.
Has walked the runway cliff, the raise, and the sale personally.
Builds the revenue engine the cautionary tales never had.
The right fit is a company where capital & focused execution can materially change the outcome within a defined window.
Send your pitch deck and a one-pager. Tell us where the company is today and what the next inflection point requires. If there's a fit, a partner responds directly to arrange the first call.
applications@eyecarecatalyst.comStrictly confidential. What you send is used only to evaluate a potential partnership, and is never shared outside our partners.